Followers | 130 |
Posts | 18112 |
Boards Moderated | 0 |
Alias Born | 01/16/2007 |
Saturday, May 27, 2017 3:35:39 AM
Crimson Forest and Hannover House Announce Specifics of First Production with U.K. Based Silver Lining Productions
CANNES, FRANCE / ACCESSWIRE / May 26, 2017 / As buyers, sellers, producers and talent wrap-up activities on the last day of the Cannes Film Festival Marche du Film, U.S. distribution partners Crimson Forest Entertainment Group, Inc. (OTC PINK: CRIM) and Hannover House, Inc. (OTC PINK: HHSE) have disclosed the first of at least two film production ventures with Silver Lining Productions of London.
"Shimmer" is a live action family-appeal feature about a young boy protecting a Welsh Dragon from nefarious outsiders. The screenplay was written and will be directed by Scott Wheeler, a noted producer and director of science-fiction, fantasy and family films as well as being an acclaimed visual effects master and founder of Rogue State (a U.S.-based post-production facility). Producers will be Grant Bradley ("Singularity") and Steve Hodges ("Bronte") along with line producer Erika Steele. Production is slated to occur this summer with principal photography occurring in and around Snowdonia, in Northern Wales. Star casting is now underway.
Executive Producers will include Eric Parkinson, Jonathan Lim and Fred Shefte. Due to the fluid nature of films in a pre-production mode, credits and other production specifics are still subject to potential change.
Crimson Forest and Hannover House have licensed all distribution rights for the USA and English-speaking provinces of Canada for "Shimmer." A USA theatrical release is planned for Spring 2018.
https://www.morningstar.com/news/access-wire/ASW_Accesswire_464311MSN/crimson-forest-and-hannover-house-announce-specifics-of-first-production-with-uk-based-silver-lining-productions.html
https://www.otcmarkets.com/stock/HHSE/news
HHSE
Recent HHSE News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 07:17:02 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM